| ASSET | YEAR | % RETURN |
|---|---|---|
BioLife Solutions (BLFS) | 1991 | 765.98% |
Shyft (SHYF) | 1991 | 591.56% |
Oppenheimer (OPY) | 1991 | 478.92% |
Vicor (VICR) | 1991 | 398.56% |
Heron Therapeuti (HRTX) | 1991 | 394.12% |
Mesa Laboratories (MLAB) | 1991 | 383.34% |
National HealthCare (NHC) | 1991 | 335.92% |
STAAR Surgical (STAA) | 1991 | 306.95% |
Celldex Therapeutics (CLDX) | 1991 | 282.61% |
Hovnanian Enterprises (HOV) | 1991 | 281.82% |
Bel Fuse A (BELFA) | 1991 | 268.43% |
ODP (ODP) | 1991 | 228.46% |
CECO Environmental (CECO) | 1991 | 224.98% |
Axogen (AXGN) | 1991 | 217.86% |
LCI Industries (LCII) | 1991 | 199.94% |
Universal (UVV) | 1991 | 187.87% |
CONMED (CNMD) | 1991 | 183.33% |
Digi International (DGII) | 1991 | 168.29% |
Tat Techno (TATT) | 1991 | 162.67% |
Cracker Barrel Old Country Store (CBRL) | 1991 | 155.86% |
Lindsay (LNN) | 1991 | 147.44% |
Great Southern Bancorp (GSBC) | 1991 | 144.89% |
Benchmark Electronics (BHE) | 1991 | 134.15% |
Matrix Service (MTRX) | 1991 | 131.82% |
Oxford Industries (OXM) | 1991 | 130.64% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
